企業プロフィール
Vaccinex 株価・ニュース・カタリスト
- ティッカー:
- VCNX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.78 USD (-6.83%)
終値
最終更新: 2026年8月17日
—
時価総額
株価変動の要因
Current closing-price context is not available for VCNX.
企業概要
事業概要
Vaccinex is a biotechnology company focused on antibody therapies and immunology, with a history of pursuing difficult oncology and neurodegenerative targets. Its story is tied to platform science and the challenge of turning it into durable value.
所在地とセクター分類
Vaccinex is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with a therapeutic platform focus.
ビジネスモデルの特徴
The business model depends on clinical validation, strategic partnerships, and capital management. Investors typically track early data, platform breadth, and whether the company can progress a narrow pipeline without dilution pressure.
バイオ業界での位置付け
Vaccinex sits in a high-risk platform-biotech niche. It remains catalyst-sensitive because the company's value depends on a limited number of programs and the market's belief in its science.
今後のカタリスト
- Vaccinex is still a broad antibody-platform story, with Alzheimer’s, Huntington’s disease, and cancer all sitting inside the same frame. That breadth is useful, but the company now needs one of those programs to move from scientific promise to something more concrete.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。